DPH00

DPH00 (also appearing as DPH00#) is an identifier associated with Disruptive Pharma, likely representing a truncated or garbled entry for one of the company's pipeline assets, such as DPH001, DPH008, or DPH00X. Disruptive Pharma specializes in the development of improved pharmaceutical formulations using its proprietary mesoporous magnesium carbonate (MMC) technology, known as Upsalite. This platform is designed to enhance the solubility and bioavailability of poorly soluble small molecule drugs by maintaining them in a stable amorphous state. The company's pipeline primarily focuses on oncology, with lead programs targeting liver, renal, and prostate cancers. As 'DPH00' does not correspond to a specific, recognized drug code in public records or the company's official documentation, it is likely a placeholder or an error in data extraction from pipeline images.